Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Abroad (travel likely)RecruitingPHASE2
Conditions
Type 1 Hyperlipoprotenemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UT southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Abhimanyu G [agarg], MD) · abhimanyu.garg@utsouthwestern.edu · 2146482895Contact: Study coordinator (Chandna Vasandani, Ph.D) · chandna.vasandani@utsouthwestern.edu · 2146485074
Study leads
Abhimanyu G Garg, MD
Principal Investigator
University of Texas Southwestern Medical Center
Chandna Vasandani, Ph.D
Study Director
University of Texas Southwestern Medical Center